Sandy Draper
Stock Analyst at Guggenheim
(4.63)
# 244
Out of 4,414 analysts
87
Total ratings
58.76%
Success rate
19.73%
Average return
Main Sectors:
25 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $453 → $464 | $397.86 | +16.62% | 10 | Apr 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $232.94 | - | 6 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $232.69 | - | 10 | Feb 15, 2024 | |
| EVH Evolent Health | Maintains: Hold | $36 → $34 | $27.27 | +24.68% | 6 | Nov 14, 2023 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $6.97 | +43.47% | 3 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $24.01 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $1.12 | +78.57% | 3 | Jun 16, 2023 | |
| ACCD Accolade | Maintains: Buy | $16 → $18 | $7.36 | +144.57% | 3 | Apr 28, 2023 | |
| ICLR ICON PLC | Maintains: Buy | $271 → $263 | $301.61 | -12.80% | 7 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $4.96 | +504.84% | 3 | Mar 6, 2023 | |
| HQY HealthEquity | Maintains: Buy | $89 → $94 | $79.75 | +17.87% | 6 | Dec 7, 2022 | |
| TDOC Teladoc Health | Upgrades: Neutral | n/a | $12.81 | - | 5 | Oct 24, 2022 | |
| PRVA Privia Health Group | Maintains: Buy | $36 → $51 | $18.03 | +182.86% | 2 | Aug 12, 2022 | |
| NTRA Natera | Maintains: Buy | n/a | $94.15 | - | 2 | May 25, 2021 | |
| VCYT Veracyte | Maintains: Buy | n/a | $20.13 | - | 2 | May 18, 2021 | |
| EXAS Exact Sciences | Maintains: Buy | n/a | $60.01 | - | 2 | May 12, 2021 | |
| HIMS Hims & Hers Health | Initiates: Hold | n/a | $12.51 | - | 1 | Apr 21, 2021 | |
| AWH Aspira Women's Health | Initiates: Buy | n/a | $3.26 | - | 1 | Mar 29, 2021 | |
| PINC Premier | Maintains: Hold | n/a | $21.06 | - | 3 | Feb 4, 2021 | |
| PSNL Personalis | Initiates: Buy | n/a | $1.55 | - | 1 | Jan 28, 2021 | |
| NEO NeoGenomics | Initiates: Buy | n/a | $13.96 | - | 1 | Jan 28, 2021 | |
| HCAT Health Catalyst | Maintains: Buy | n/a | $6.31 | - | 2 | Apr 22, 2020 | |
| VEEV Veeva Systems | Maintains: Buy | n/a | $198.90 | - | 2 | Mar 26, 2020 | |
| MDRX Veradigm | Downgrades: Hold | n/a | $7.82 | - | 1 | Jan 16, 2018 | |
| INCR InterCure | Upgrades: Buy | n/a | $2.96 | - | 2 | May 31, 2017 |
Medpace Holdings
Apr 24, 2024
Maintains: Buy
Price Target: $453 → $464
Current: $397.86
Upside: +16.62%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $232.94
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $232.69
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36 → $34
Current: $27.27
Upside: +24.68%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $6.97
Upside: +43.47%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $24.01
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $1.12
Upside: +78.57%
Accolade
Apr 28, 2023
Maintains: Buy
Price Target: $16 → $18
Current: $7.36
Upside: +144.57%
ICON PLC
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $301.61
Upside: -12.80%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $4.96
Upside: +504.84%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $79.75
Upside: +17.87%
Teladoc Health
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $12.81
Upside: -
Privia Health Group
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $18.03
Upside: +182.86%
Natera
May 25, 2021
Maintains: Buy
Price Target: n/a
Current: $94.15
Upside: -
Veracyte
May 18, 2021
Maintains: Buy
Price Target: n/a
Current: $20.13
Upside: -
Exact Sciences
May 12, 2021
Maintains: Buy
Price Target: n/a
Current: $60.01
Upside: -
Hims & Hers Health
Apr 21, 2021
Initiates: Hold
Price Target: n/a
Current: $12.51
Upside: -
Aspira Women's Health
Mar 29, 2021
Initiates: Buy
Price Target: n/a
Current: $3.26
Upside: -
Premier
Feb 4, 2021
Maintains: Hold
Price Target: n/a
Current: $21.06
Upside: -
Personalis
Jan 28, 2021
Initiates: Buy
Price Target: n/a
Current: $1.55
Upside: -
NeoGenomics
Jan 28, 2021
Initiates: Buy
Price Target: n/a
Current: $13.96
Upside: -
Health Catalyst
Apr 22, 2020
Maintains: Buy
Price Target: n/a
Current: $6.31
Upside: -
Veeva Systems
Mar 26, 2020
Maintains: Buy
Price Target: n/a
Current: $198.90
Upside: -
Veradigm
Jan 16, 2018
Downgrades: Hold
Price Target: n/a
Current: $7.82
Upside: -
InterCure
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $2.96
Upside: -